These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 22456298

  • 1. Population pharmacokinetics of mycophenolate mofetil in Thai lupus nephritis patients.
    Punyawudho B, Lertdumrongluk P, Somparn P, Kittanamongkolchai W, Traitanon O, Avihingsanon Y, Vadcharavivad S.
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):272-80. PubMed ID: 22456298
    [Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis.
    Romano-Aguilar M, Reséndiz-Galván JE, Medellín-Garibay SE, Milán-Segovia RDC, Martínez-Martínez MU, Abud-Mendoza C, Romano-Moreno S.
    Lupus; 2020 Aug; 29(9):1067-1077. PubMed ID: 32539658
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.
    Yu ZC, Zhou PJ, Wang XH, Françoise B, Xu D, Zhang WX, Chen B.
    Acta Pharmacol Sin; 2017 Nov; 38(11):1566-1579. PubMed ID: 28836585
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients-implications for therapeutic drug monitoring.
    Łuszczyńska P, Pawiński T, Kunicki PK, Durlik M, Augustyniak-Bartosik H, Hurkacz M.
    Eur J Clin Pharmacol; 2019 Mar; 75(3):371-379. PubMed ID: 30430214
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen.
    Reséndiz-Galván JE, Romano-Aguilar M, Medellín-Garibay SE, Milán-Segovia RDC, Niño-Moreno PDC, Jung-Cook H, Chevaile-Ramos JA, Romano-Moreno S.
    Eur J Pharm Sci; 2020 Jul 01; 150():105370. PubMed ID: 32387086
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies.
    Zahr N, Amoura Z, Debord J, Hulot JS, Saint-Marcoux F, Marquet P, Piette JC, Lechat P.
    Clin Pharmacokinet; 2008 Jul 01; 47(4):277-84. PubMed ID: 18336056
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.
    Yap DYH, Tam CH, Yung S, Wong S, Tang CSO, Mok TMY, Yuen CKY, Ma MKM, Lau CS, Chan TM.
    Nephrol Dial Transplant; 2020 May 01; 35(5):810-818. PubMed ID: 30215770
    [Abstract] [Full Text] [Related]

  • 14. Population Pharmacokinetics and Limited Sampling Strategy of Mycophenolate Mofetil for Indian Patients With Lupus Nephritis.
    Koloskoff K, Panwar R, Rathi M, Mathew S, Sharma A, Marquet P, Benito S, Woillard JB, Pattanaik S.
    Ther Drug Monit; 2024 Oct 01; 46(5):567-574. PubMed ID: 38723153
    [Abstract] [Full Text] [Related]

  • 15. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
    Mino Y, Naito T, Matsushita T, Otsuka A, Ushiyama T, Ozono S, Hishida A, Kagawa Y, Kawakami J.
    Ther Drug Monit; 2008 Dec 01; 30(6):656-61. PubMed ID: 18978521
    [Abstract] [Full Text] [Related]

  • 16. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.
    Abd Rahman AN, Tett SE, Staatz CE.
    Clin Pharmacokinet; 2013 May 01; 52(5):303-31. PubMed ID: 23475567
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children.
    Barau C, Furlan V, Debray D, Taburet AM, Barrail-Tran A.
    Br J Clin Pharmacol; 2012 Sep 01; 74(3):515-24. PubMed ID: 22329639
    [Abstract] [Full Text] [Related]

  • 19. Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring.
    Zabotti A, Baraldo M, Quartuccio L, Sacco S, De Marchi G, De Vita S.
    Clin Rheumatol; 2015 Jan 01; 34(1):171-4. PubMed ID: 25249327
    [Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil.
    Ling J, Shi J, Jiang Q, Jiao Z.
    Eur J Clin Pharmacol; 2015 Jan 01; 71(1):95-106. PubMed ID: 25327506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.